- Scientists funded by Cancer Research UK have developed a groundbreaking urine test for early lung cancer detection, which could be rolled out across the NHS within five years.
- The innovative test identifies specific “zombie” cell proteins that signal the presence of early-stage lung cancer, potentially months or years before symptoms manifest.
- This breakthrough aims to revolutionise early diagnosis, as most lung cancer cases in England are currently identified at advanced stages, significantly reducing survival chances.
- Researchers at the University of Cambridge created a sensor that interacts with these zombie cell proteins, releasing an easily detectable compound into urine.
- While further clinical trials are necessary, the simple urine analysis holds potential as a routine screening method and may also be adapted for detecting other lung diseases and cancers.
IN FULL